Disruptive Technology for Clinical Trials Europe 2025 Speakers

Cristina De Juan PhD of UCB speaking at AMG World

Cristina De Juan PhD

Global Clinical Sciences & Operations Innovation Lead

UCB

Marta Carrasco of Roche speaking at AMG World

Marta Carrasco

Data Insights Development Leader

Roche

Dr Fabian Kreimendahl of The Janssen Pharmaceutical Companies of Johnson & Johnson speaking at AMG World

Dr Fabian Kreimendahl

Medical Evidence Biostatistics Manager

The Janssen Pharmaceutical Companies of Johnson & Johnson

Andrew Gvozdanovic of Novo Nordisk speaking at AMG World

Andrew Gvozdanovic

International Medical Manager

Novo Nordisk

Paul Cooper of Roche speaking at AMG World

Paul Cooper

Healthcare Strategy Leader

Roche

Dr Sachin S Shah of GSK speaking at AMG World

Dr Sachin S Shah

Digital Biomarker Lead

GSK

Samantha Warden of GSK speaking at AMG World

Samantha Warden

Global Head, Clinical Programming & Business Excellence

GSK

Dr Daphne Hazell of Home Wound Care speaking at AMG World

Dr Daphne Hazell

CEO

Home Wound Care

Guido Radack of Bayer speaking at AMG World

Guido Radack

Former VP of Digital Transformation in Clinical Development

Bayer

Piotr Maślak of AstraZeneca speaking at AMG World

Piotr Maślak

Director, Operational Data Intelligence

AstraZeneca

Alexandre Malouvier of ICON PLC speaking at AMG World

Alexandre Malouvier

Senior Director Scientific Affairs & Digital Innovation

ICON PLC

Nathan Noakes of Parexel speaking at AMG World

Nathan Noakes

Sensor Solutions Director

Parexel

Marcus Greenhill of Analog Devices speaking at AMG World

Marcus Greenhill

Sales Director Digital Healthcare (Pharma) Systems EMEA

Analog Devices

Ming-Yuang Tseng MD PHD of AstraZeneca speaking at AMG World

Ming-Yuang Tseng MD PHD

Director Global Regulatory Affairs (CVRM)

AstraZeneca